Breen Susan, Solomon Peter S, Bedon Frank, Vincent Delphine
Plant Sciences Division, Research School of Biology, The Australian National University Canberra, ACT, Australia.
Department of Economic Development, AgriBio Bundoora, VIC, Australia ; AgriBio, La Trobe University Bundoora, VIC, Australia.
Front Plant Sci. 2015 Oct 27;6:900. doi: 10.3389/fpls.2015.00900. eCollection 2015.
Antimicrobial peptides (AMPs) are natural products found across diverse taxa as part of the innate immune system against pathogen attacks. Some AMPs are synthesized through the canonical gene expression machinery and are called ribosomal AMPs. Other AMPs are assembled by modular enzymes generating nonribosomal AMPs and harbor unusual structural diversity. Plants synthesize an array of AMPs, yet are still subject to many pathogen invasions. Crop breeding programs struggle to release new cultivars in which complete disease resistance is achieved, and usually such resistance becomes quickly overcome by the targeted pathogens which have a shorter generation time. AMPs could offer a solution by exploring not only plant-derived AMPs, related or unrelated to the crop of interest, but also non-plant AMPs produced by bacteria, fungi, oomycetes or animals. This review highlights some promising candidates within the plant kingdom and elsewhere, and offers some perspectives on how to identify and validate their bioactivities. Technological advances, particularly in mass spectrometry (MS) and nuclear magnetic resonance (NMR), have been instrumental in identifying and elucidating the structure of novel AMPs, especially nonribosomal peptides which cannot be identified through genomics approaches. The majority of non-plant AMPs showing potential for plant disease immunity are often tested using in vitro assays. The greatest challenge remains the functional validation of candidate AMPs in plants through transgenic experiments, particularly introducing nonribosomal AMPs into crops.
抗菌肽(AMPs)是在不同生物分类群中发现的天然产物,是抵御病原体攻击的固有免疫系统的一部分。一些抗菌肽通过经典的基因表达机制合成,被称为核糖体抗菌肽。其他抗菌肽则由模块化酶组装而成,产生非核糖体抗菌肽,并具有独特的结构多样性。植物能合成一系列抗菌肽,但仍易受多种病原体的侵袭。作物育种计划难以培育出具有完全抗病性的新品种,而且通常这种抗性会很快被世代周期较短的目标病原体克服。抗菌肽可能提供一种解决方案,不仅可以探索与目标作物相关或不相关的植物源抗菌肽,还可以探索由细菌、真菌、卵菌或动物产生的非植物抗菌肽。本综述重点介绍了植物界及其他领域一些有前景的候选抗菌肽,并就如何鉴定和验证它们的生物活性提供了一些观点。技术进步,特别是在质谱(MS)和核磁共振(NMR)方面的进步,有助于鉴定和阐明新型抗菌肽的结构,尤其是那些无法通过基因组学方法鉴定的非核糖体肽。大多数显示出对植物病害具有免疫潜力的非植物抗菌肽通常通过体外试验进行测试。最大的挑战仍然是通过转基因实验在植物中对候选抗菌肽进行功能验证,特别是将非核糖体抗菌肽导入作物中。